NCT07102368View on ClinicalTrials.gov

A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

January 15, 2029

Study Completion Date

January 15, 2029

Conditions

Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease

Trial Locations (1)

10825

RECRUITING

Praxis Fur Gastroenteroligie, Berlin

All Listed Sponsors

lead

Janssen-Cilag G.m.b.H

INDUSTRY

NCT07102368 - A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany | Biotech Hunter | Biotech Hunter